Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Int J Cancer. 2010 Aug 1;127(3):657–666. doi: 10.1002/ijc.25067

Table 2.

Secondary solid tumors and leukemias, by time from WT to SMN diagnosis

Time from WT to SMN (yr) 0–9 10–19 20–29 30+ Total
Solid tumors (by 2-digit primary site code): 37 69 49 19 174
 Lip, oral cavity, pharynx (C07,09) 2 3 1 0 6
 Digestive organs (C16-8,20,22,25-6) 4 12 12 3 31
 Respiratory, intrathoracic (C34,37-8) 2 5 2 0 9
 Bones, joints, cartilage (C40-1) 5 11 4 0 20
 Skin (malignant melanoma) (C44) 2 1 1 2 6
 Peripheral, autonomic nervous system (C47) 0 3 2 0 5
 Retroperitoneum, peritoneum (C48) 1 1 1 0 3
 Connective, subcutaneous, soft tissue (C49) 3 4 4 0 11
 Breast (C50) 0 7 8 8 23
 Female and male genital organs (C53-5, 62-3) 1 1 5 1 8
 Urinary tract (C64,67) 3 4 3 0 10
 Eye, brain other CNS (C69-72) 9 3 4 1 17
 Thyroid and other endocrine (C73-5) 2 11 2 3 18
 Lymph nodes (C77) 3 3 0 0 6
 Other and ill defined (C76) 0 0 0 1 1
Leukemias (by morphology): 24 2 2 0 28
 Acute lymphoblastic leukemia (M9821) 2 0 1 0 3
 Myeloid and monocytic leukemia (M9861,63,66,91) 17 2 1 0 20
 Myelodysplastic syndrome (M9987) 5 0 0 0 5